The authors introduce the idea of asymmetrical tolerance intervals as an aid in fully assessing product performance relative to product or process requirements.
Unused, misused, or misunderstood, statistical tolerance intervals are fundamentally different from statistical confidence intervals, which provide interval estimates for summary statistics, such as mean and standard deviation. Tolerance intervals were developed as a tool to provide confidence intervals for a population proportion. With insights gained, the tolerance interval can be effectively used to develop product and process specifications as well as determine conformance to requirements.
Statistical tolerance intervals are routinely used to assess a product’s conformance to requirements and to provide a range within which one can expect product attributes to be contained. In this paper, the authors focus on parametric tolerance intervals that assume normally distributed data. The authors introduce the idea of asymmetrical tolerance intervals as an aid in fully assessing product performance relative to product or process requirements.Tolerance intervals are generated by collecting data through sampling of representative product and processes and using tolerance interval factors (k) to create the tolerance limits. Tolerance interval factors are widely available in tables and available in many statistical computer programs.
Click here for a PDF of the article.Lynn D. Torbeck is a statistician with Torbeck and Associates. Chuck Pheatt is Professor Emeritus with Emporia State University.
Pharmaceutical Technology
Volume 45, Number 12
December 2021
Page: 38–42
When referring to this article, please cite it as L. D. Torbeck and C. Pheatt, “Using Tolerance Intervals to Assess Conformance to Requirements,” Pharmaceutical Technology 45 (12) 2021.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.